Arkolith/Insider Trading/MAIA/Form 4

Smith Stan

DirectorMAIA Biotechnology, Inc. (MAIA) · full profile →Form 4 · filed Oct 2, 2025
Net Buying
Open-Market Buys
$25K
Open-Market Sells
$0
Net Open-Market Flow
$25K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 1, 2025Buy(P)19K$1.30$25K1.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 1, 2025Buy(P)19K$1.57$30K19K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001878313-25-000019) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML